Search   
MSDS  : Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol -1-ylmethyl)-1,3-diox olan- 4-yl)methoxy)phenyl)-, cis-
CAS  : 65277-42-1
SYNONYMS  : * Fungarest * Fungoral * Ketoconazol * Ketoconazole * Ketoderm * Ketoisdin * KW-1414 * Nizoral * Orifungal M * Panfungol * R 41400
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : TK7912300
CHEMICAL NAME : Piperazine,
1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol
-1-ylmethyl)-1,3-diox olan- 4-yl)methoxy)phenyl)-,
cis-
CAS REGISTRY NUMBER : 65277-42-1
BEILSTEIN REFERENCE NO. : 4303081
LAST UPDATED : 199612
DATA ITEMS CITED : 31
MOLECULAR FORMULA : C26-H28-Cl2-N4-O4
MOLECULAR WEIGHT : 531.48
WISWESSER LINE NOTATION : T6N DNTJ AV1 DR DO1- DT5O COTJ BR BG DG& B1- AT5N CNJ
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* Fungarest
* Fungoral
* Ketoconazol
* Ketoconazole
* Ketoderm
* Ketoisdin
* KW-1414
* Nizoral
* Orifungal M
* Panfungol
* R 41400

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 45 mg/kg/17D-I
TOXIC EFFECTS :
Behavioral - coma
Liver - jaundice, other or unclassified
REFERENCE :
GUTTAK Gut. (British Medical Journal, Box 560B, Kennebunkport, ME 04046)
V.1- 1960- Volume(issue)/page/year: 26,636,1986

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 412 mg/kg/15W-I
TOXIC EFFECTS :
Behavioral - coma
Liver - hepatitis (hepatocellular necrosis), diffuse
Liver - jaundice, other or unclassified
REFERENCE :
GUTTAK Gut. (British Medical Journal, Box 560B, Kennebunkport, ME 04046)
V.1- 1960- Volume(issue)/page/year: 26,636,1986

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 264 mg/kg/66D-I
TOXIC EFFECTS :
Liver - other changes
REFERENCE :
GASTAB Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1943- Volume(issue)/page/year: 86,503,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - child
DOSE/DURATION : 450 mg/kg/90D-I
TOXIC EFFECTS :
Endocrine - evidence of thyroid hypofunction
Nutritional and Gross Metabolic - other changes
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House,
Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year:
293,993,1986

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 49 mg/kg/17D-I
TOXIC EFFECTS :
Liver - other changes
REFERENCE :
GASTAB Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1943- Volume(issue)/page/year: 86,503,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - woman
DOSE/DURATION : 60 mg/kg
TOXIC EFFECTS :
Liver - other changes
REFERENCE :
GASTAB Gastroenterology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1943- Volume(issue)/page/year: 86,503,1984

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 166 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 1474 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 18,474,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >2400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 18,474,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 86 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRUGAY Drugs. International Journal of Current Therapeutics and Applied
Pharmacology Reviews. (ADIS Press International Inc., Suite B-30, Oxford
Ct. Business Center, 582 Middletown Blvd., Langhorne, PA 19047) V.1- 1971-
Volume(issue)/page/year: 23,1,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 618 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 2937 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 18,474,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 18,474,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 32 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for
Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
Volume(issue)/page/year: 33,895,1989

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 178 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 23300 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 178 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - guinea pig
DOSE/DURATION : 23300 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos
540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year:
17,373,1981

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 1200 mg/kg/30D-I
TOXIC EFFECTS :
Liver - other changes
Liver - changes in liver weight
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1426,1984

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE : 1029 mg/kg
SEX/DURATION : male 60 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - other effects on male
Endocrine - androgenic
REFERENCE :
ACENA7 Acta Endocrinologica (Copenhagen). (Periodica, Skolegade 12 E,
DK-2500 Valby, Denmark) V.1- 1948- Volume(issue)/page/year: 110,276,1985

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 6480 mg/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating - 7 day(s) after
conception
TOXIC EFFECTS :
Reproductive - Fertility - mating performance (e.g. # sperm positive females
per # females mated; # copulations per # estrus cycles)
Reproductive - Fertility - female fertility index (e.g. # females pregnant
per # sperm positive females; # females pregnant per # females mated)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1433,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 600 mg/kg
SEX/DURATION : male 3 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material,
sperm morphology, motility, and count)
Reproductive - Fertility - male fertility index (e.g. # males impregnating
females per # males exposed to fertile nonpregnant females)
REFERENCE :
CCPTAY Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1-
1970- Volume(issue)/page/year: 41,411,1990

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 3240 mg/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating - 7 day(s) after
conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in
number of implants per female; total number of implants per corpora lutea)
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1433,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 880 mg/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetal death
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1433,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 1040 mg/kg
SEX/DURATION : female 17-21 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1433,1984

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 300 mg/kg
SEX/DURATION : male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - other effects on male
REFERENCE :
JOAND3 Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept.,
2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980-
Volume(issue)/page/year: 13,191,1992

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 300 mg/kg
SEX/DURATION : male 1 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material,
sperm morphology, motility, and count)
REFERENCE :
JOAND3 Journal of Andrology. (Lippincott/Harper, Journal Fulfillment Dept.,
2350 Virginia Ave., Hagerstown, MD 21740) V.1- 1980-
Volume(issue)/page/year: 13,191,1992

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 520 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 18,1433,1984

** MUTATION DATA **

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Lymphocyte
DOSE/DURATION : 10 mg/L
REFERENCE :
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for
Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
Volume(issue)/page/year: 24,478,1983

TYPE OF TEST : DNA inhibition
TEST SYSTEM : Human Cells - not otherwise specified
DOSE/DURATION : 1 umol/L
REFERENCE :
TUMOAB Tumori. (Casa Editrice Ambrosiana, Via G. Frua 6, 20146 Milan,
Italy) V.1- 1911- Volume(issue)/page/year: 77,385,1991

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - X6059
No. of Facilities: 30 (estimated)
No. of Industries: 1
No. of Occupations: 3
No. of Employees: 1045 (estimated)
No. of Female Employees: 620 (estimated)


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
1-Piperazineacetic acid, 4-phenyl-,(((2-chloro-4-nitrophenyl)azo)(2-hydroxyphenyl)methylene)hydrazide 127718-36-9
1-Piperazineacetic acid, 4-phenyl-,(((2-chlorophenyl)azo)(2-hydroxyphenyl)methylene)hydrazide 127718-37-0
1-Piperazineacetic acid, 4-phenyl-,(((3-chlorophenyl)azo)(2-hydroxyphenyl)methylene)hydrazide 127718-38-1
1-Piperazineacetic acid, 4-phenyl-,(((4-chlorophenyl)azo)(2-hydroxyphenyl)methylene)hydrazide 127718-39-2
1-Piperazineacetic acid, 4-phenyl-,(((2-chlorophenyl)azo)phenylmethylene)hydrazide 127718-31-4
1-Piperazineacetic acid, 4-phenyl-,(((3-chlorophenyl)azo)phenylmethylene)hydrazide 127718-32-5
1-Piperazineacetic acid, 4-phenyl-,(((4-chlorophenyl)azo)phenylmethylene)hydrazide 127718-33-6
Phthalic acid, 3-amino-, 1-butyl2-(2-(diethylamino)ethyl) ester, hydrobromide 127718-33-6
1-Piperazineacetic acid, 4-phenyl-,((2,3-dimethoxyphenyl)methylene)hydrazide 67041-06-9
1-Piperazineacetic acid, 4-phenyl-,((3,4-dimethoxyphenyl)methylene)hydrazide 67041-07-0
1-Piperazineacetic acid, 4-phenyl-, ethyl ester 56968-26-4
1-Piperazineacetic acid, 4-phenyl-,((3-hydroxy-4-methoxyphenyl)methylene)hydrazide 67041-04-7
1-Piperazineacetic acid, 4-phenyl-,((2-hydroxyphenyl)(2-methylphenylazo)methylene)hydrazide 127718-40-5
1-Piperazineacetic acid, 4-phenyl-,((2-hydroxyphenyl)(phenylazo)methylene)hydrazide 127718-35-8
1-Piperazineacetic acid, alpha-phenyl-,2-(p-methoxybenzylidene)hydrazide 127718-35-8
1-Piperazineacetic acid, 4-phenyl-,(((4-methoxyphenyl)azo)phenylmethylene)hydrazide 127718-34-7
1-Piperazineacetic acid, 4-phenyl-,2-(5-nitrofurfurylidene)hydrazide 33165-35-4
1-Piperazineacetic acid, 4-phenyl-,(phenylmethylene)hydrazide 67041-03-6
Phthalic acid, 3-amino-, 2-sec-butyl1-(2-(diethylamino)ethyl) ester, hydrobromide 67041-03-6
1-Piperazineacetic acid, 4-piperonyl-,(2-oxo-3-indolinylidene)hydrazide (Z)- 86873-44-1
1-Piperazineacetic acid, 4-(4-pyridyl)-,(2-oxo-3-indolinylidene)hydrazide, (Z)- 86889-04-5
1-Piperazineacetic acid,4-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)-alpha- methyl-, ethyl ester, (E)-2-butenedioate(1:2) 65274-47-7
1-Piperazineacetic acid,4-(3,4,5-trimethoxycinnamoyl)-, ethyl ester,hydrochloride 26219-22-7
1-Piperazineacetic acid,4-(3,4,5-trimethoxycinnamoyl)-, ethyl ester, maleate 24536-75-2
1-Piperazineacetic acid,4-((2,3,4-trimethoxyphenyl)methyl)-, 4-methoxyphenylester, dihydrochloride 113594-65-3
1-Piperazineacetic acid,4-((3,4,5-trimethoxyphenyl)methyl)-, 4-methoxyphenylester, (E)-2- butenedioate, hydrate (1:2:1) 113594-68-6
1-Piperazineacetonitrile,alpha-methyl-3-oxo-2-phenyl- 113594-68-6
1-Piperazineacetonitrile, 3-oxo-2-phenyl- 113594-68-6
1-Piperazineaceto-2',6'-xylidide,4-(4,4-bis(p-fluorophenyl)butyl)- 3416-26-0
Phthalic acid, 3-amino-, 2-butyl1-(2-(diethylamino)ethyl) ester, hydrochloride 3416-26-0
Piperazine, 1-acetyl-4-(o-chlorobenzyl)-,hydrochloride 18907-59-0
Piperazine,1-acetyl-4-(4-(2-(2-chlorophenyl)-3-(1H-imidazol-1-yl)oxiranyl)phenyl)- 79478-72-1
Piperazine,1-(3-(3-acetyl-4-(p-chlorophenyl)piperidino)propyl)-4-methyl-, trihydrochloride 39426-77-2
Piperazine,1-(2-((2-acetyl-4-chlorophenyl)thio)benzoyl)-4-methyl-, monohydrochloride 93289-05-5
Piperazine,1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-diox olan- 4-yl)methoxy)phenyl)-,cis- 65277-42-1
Piperazine, 1-acetyl-2,6-dimethyl-4-nitroso- 75881-17-3
Piperazine,1-acetyl-4-(1-(hydroxyimino)-2-oxopropyl)- 150012-64-9
Piperazine,1-((7-acetyl-6-hydroxy-5-methoxy-3-methylbenzofuran-2-yl)carbonyl)-4-methy l-, monohydrochloride 150012-64-9
Piperazine,1-((7-acetyl-6-hydroxy-5-methoxy-3-methylbenzofuran-2-yl)carbonyl)-4-pheny l- 150012-64-9
Piperazine,1-acetyl-4-(2-(6-methoxy-2-naphthalenyl)propyl)- 72278-79-6
Phthalic acid, 3-amino-, 1-(3-(dibutylamino)propyl)2-propyl ester, hydrochloride 72278-79-6
Piperazine,1-acetyl-4-(1-(4-methoxyphenyl)-3-phenylpropyl)-,(Z)-2-butenedioate (1:1) 40028-25-9
Piperazine,1-(2-acetyl-1-oxohexyl)-4-(2-pyrimidinyl)- 164468-04-6
Piperazine,1-(4-(2-(acetyloxy)-5-methoxyphenyl)-1-oxo-4-phenylbutyl)-4-methyl- 104712-26-7
Piperazine,1-((4-acetylphenoxy)acetyl)-4-(4-chlorophenyl)- 31189-05-6
Piperazine, 1-acetyl-4-(phenylallyl)-, hydrochloride 18907-69-2
Piperazine, 1-acetyl-4-phenyl-, hydrochloride 18907-50-1
Piperazine,1-acetyl-4-((2-(phenylmethyl)phenyl)methyl)-,(Z)-2-butenedioate 37652-71-4
Piperazine,1-(4-acetylphenyl)-4-(3-pyridinylcarbonyl)- 124444-91-3
Piperazine,1-(4-acetylphenyl)-4-(3-pyridinylcarbonyl)-,monohydrochloride 124444-92-4

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net